These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 19388928

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype.
    Urosevic M, Conrad C, Kamarashev J, Asagoe K, Cozzio A, Burg G, Dummer R.
    Hum Pathol; 2005 Sep; 36(9):1020-4. PubMed ID: 16153467
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dendritic cell deficiencies in pediatric acute lymphoblastic leukemia patients.
    Maecker B, Mougiakakos D, Zimmermann M, Behrens M, Hollander S, Schrauder A, Schrappe M, Welte K, Klein C.
    Leukemia; 2006 Apr; 20(4):645-9. PubMed ID: 16498391
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group.
    Tsagarakis NJ, Kentrou NA, Papadimitriou KA, Pagoni M, Kokkini G, Papadaki H, Pappa V, Marinakis T, Anagnostopoulos NI, Vadikolia C, Anagnostopoulos A, Angelopoulou MK, Terpos E, Poziopoulos C, Anargyrou K, Rontogianni D, Papadaki T, Psarra A, Kontopidou FN, Skoumi D, Papadhimitriou SI, Paterakis G, Hellenic Dendritic Cell Leukemia Study Group.
    Leuk Res; 2010 Apr; 34(4):438-46. PubMed ID: 19793612
    [Abstract] [Full Text] [Related]

  • 8. Expression of dendritic cell markers CD11c/BDCA-1 and CD123/BDCA-2 in coronary artery disease upon activation in whole blood.
    Van Brussel I, Van Vré EA, De Meyer GR, Vrints CJ, Bosmans JM, Bult H.
    J Immunol Methods; 2010 Oct 31; 362(1-2):168-75. PubMed ID: 20888334
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets.
    Beckebaum S, Zhang X, Chen X, Yu Z, Frilling A, Dworacki G, Grosse-Wilde H, Broelsch CE, Gerken G, Cicinnati VR.
    Clin Cancer Res; 2004 Nov 01; 10(21):7260-9. PubMed ID: 15534100
    [Abstract] [Full Text] [Related]

  • 11. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY, Sun XF, Yan SL, He LR, Zhen ZJ, Xia Y.
    Ai Zheng; 2007 Apr 01; 26(4):418-22. PubMed ID: 17430665
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Acute myeloid dendritic cell leukaemia with specific cutaneous involvement: a diagnostic challenge.
    Ferran M, Gallardo F, Ferrer AM, Salar A, Pérez-Vila E, Juanpere N, Salgado R, Espinet B, Orfao A, Florensa L, Pujol RM.
    Br J Dermatol; 2008 May 01; 158(5):1129-33. PubMed ID: 18294313
    [Abstract] [Full Text] [Related]

  • 14. HLA-DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia.
    Oelschlaegel U, Mohr B, Schaich M, Schäkel U, Kroschinsky F, Illmer T, Ehninger G, Thiede C.
    Cytometry B Clin Cytom; 2009 Sep 01; 76(5):321-7. PubMed ID: 19291801
    [Abstract] [Full Text] [Related]

  • 15. Plasmacytoid dendritic cell leukemia with potent antigen-presenting ability.
    Narita M, Kuroha T, Watanabe N, Hashimoto S, Tsuchiyama J, Tochiki N, Saitoh A, Satoh N, Furukawa T, Toba K, Fuse I, Aizawa Y, Takahashi M.
    Acta Haematol; 2008 Sep 01; 120(2):91-9. PubMed ID: 18948686
    [Abstract] [Full Text] [Related]

  • 16. Interleukin (IL)-3/granulocyte macrophage-colony stimulating factor/IL-5 receptor alpha and beta chains are preferentially expressed in acute myeloid leukaemias with mutated FMS-related tyrosine kinase 3 receptor.
    Riccioni R, Diverio D, Riti V, Buffolino S, Mariani G, Boe A, Cedrone M, Ottone T, Foà R, Testa U.
    Br J Haematol; 2009 Feb 01; 144(3):376-87. PubMed ID: 19036083
    [Abstract] [Full Text] [Related]

  • 17. Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1.
    Sanna A, Huang YM, Arru G, Fois ML, Link H, Rosati G, Sotgiu S.
    Mult Scler; 2008 Nov 01; 14(9):1199-207. PubMed ID: 18653740
    [Abstract] [Full Text] [Related]

  • 18. Clinical Characteristics and Diagnosis of Acute Myeloid Leukemia with CD56-Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Zhang X, Wu Y, Li C, Shen K, Li R.
    Clin Lab; 2023 Jun 01; 69(6):. PubMed ID: 37307129
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells.
    Jacob MC, Chaperot L, Mossuz P, Feuillard J, Valensi F, Leroux D, Béné MC, Bensa JC, Brière F, Plumas J.
    Haematologica; 2003 Aug 01; 88(8):941-55. PubMed ID: 12935983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.